The Impact of COVID-19 on Syringe Services Programs in the United States

Affiliations

¹ School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA. snglick@uw.edu.
² Dave Purchase Project, North American Syringe Exchange Network, Tacoma, WA, USA.
³ School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
⁴ College of Global Public Health, New York University, New York, NY, USA.

Editorial

Sara N Glick et al. AIDS Behav. 2020 Sep.

. 2020 Sep;24(9):2466-2468.

doi: 10.1007/s10461-020-02886-2.

¹ School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA. snglick@uw.edu.
² Dave Purchase Project, North American Syringe Exchange Network, Tacoma, WA, USA.
³ School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
⁴ College of Global Public Health, New York University, New York, NY, USA.

No abstract available

References

1. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–991. doi: 10.1016/S0140-6736(96)02536-6. - DOI - PubMed
1. Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR. Availability of HIV and HCV on-site testing and treatment at syringe service programs in the United States. J Acquir Immune Defic Syndr. 2018;79(2):e76–e78. doi: 10.1097/QAI.0000000000001792. - DOI - PMC - PubMed
1. Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, et al. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington. Subst Abuse. 2019;12:1–9. - PubMed
1. Bachhuber MA, Thompson C, Prybylowski A, Benitez J, Mazzella S, Barclay D. Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program. Subst Abuse. 2018;39(2):167–172. doi: 10.1080/08897077.2018.1443541. - DOI - PMC - PubMed
1. Jones CM. Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. Int J Drug Policy. 2019;70:22–32. doi: 10.1016/j.drugpo.2019.04.006. - DOI - PubMed